Man Group’s Corcept Therapeutics CORT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$30.1M Sell
410,139
-219,036
-35% -$16.1M 0.06% 339
2025
Q1
$71.9M Buy
629,175
+341,295
+119% +$39M 0.18% 103
2024
Q4
$14.5M Sell
287,880
-62,653
-18% -$3.16M 0.04% 498
2024
Q3
$16.2M Sell
350,533
-479,410
-58% -$22.2M 0.04% 479
2024
Q2
$27M Sell
829,943
-668,977
-45% -$21.7M 0.07% 327
2024
Q1
$37.8M Buy
1,498,920
+672,819
+81% +$16.9M 0.1% 225
2023
Q4
$26.8M Buy
+826,101
New +$26.8M 0.07% 299
2023
Q3
Sell
-615,925
Closed -$13.7M 445
2023
Q2
$13.7M Buy
+615,925
New +$13.7M 0.04% 514
2023
Q1
Sell
-685,386
Closed -$13.9M 441
2022
Q4
$13.9M Sell
685,386
-63,015
-8% -$1.28M 0.05% 438
2022
Q3
$19.2M Buy
+748,401
New +$19.2M 0.09% 265
2022
Q2
Sell
-445,740
Closed -$10M 225
2022
Q1
$10M Sell
445,740
-4,674
-1% -$105K 0.03% 603
2021
Q4
$8.92M Buy
450,414
+42,549
+10% +$842K 0.03% 641
2021
Q3
$8.03M Buy
407,865
+34,818
+9% +$685K 0.03% 654
2021
Q2
$8.21M Buy
373,047
+84,292
+29% +$1.85M 0.03% 671
2021
Q1
$6.87M Sell
288,755
-37,575
-12% -$894K 0.03% 567
2020
Q4
$8.54M Sell
326,330
-449,798
-58% -$11.8M 0.04% 505
2020
Q3
$13.5M Buy
776,128
+285,174
+58% +$4.96M 0.05% 380
2020
Q2
$8.26M Sell
490,954
-260,753
-35% -$4.39M 0.04% 435
2020
Q1
$8.94M Buy
751,707
+155,912
+26% +$1.85M 0.06% 324
2019
Q4
$7.21M Buy
595,795
+375,033
+170% +$4.54M 0.02% 842
2019
Q3
$3.12M Buy
220,762
+44,308
+25% +$626K 0.01% 1082
2019
Q2
$1.97M Sell
176,454
-261,363
-60% -$2.91M 0.01% 1305
2019
Q1
$5.14M Buy
437,817
+146,048
+50% +$1.71M 0.02% 905
2018
Q4
$3.9M Sell
291,769
-178,623
-38% -$2.39M 0.02% 887
2018
Q3
$6.6M Buy
470,392
+335,409
+248% +$4.7M 0.02% 832
2018
Q2
$2.12M Sell
134,983
-54,650
-29% -$859K 0.01% 1329
2018
Q1
$3.12M Buy
+189,633
New +$3.12M 0.01% 1073